|
| | Publication Year | Title | Author(s) |
| 1 | 16-Sep-2020 | Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma. | Faridi, Pouya; Woods, Katherine; Ostrouska, Simone; Deceneux, Cyril; Aranha, Ritchlynn; Duscharla, Divya; Wong, Stephen Q; Chen, Weisan; Ramarathinam, Sri H; Lim Kam Sian, Terry C C; Croft, Nathan P; Li, Chen; Ayala, Rochelle; Cebon, Jonathan S ; Purcell, Anthony W; Schittenhelm, Ralf B; Behren, Andreas |
| 2 | Apr-2020 | Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. | Cebon, Jonathan S ; Gore, Martin; Thompson, John F; Davis, Ian D; McArthur, Grant A; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P N; Hersey, Peter; Evans, T R Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G; Corrie, Pippa G; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M; Endo-Munoz, Liliana; Tutuka, Candani S A; Venhaus, Ralph; Old, Lloyd J; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan |
| 3 | 2018 | Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide. | Chan, Kok Fei; Gully, Benjamin S; Gras, Stephanie; Beringer, Dennis X; Kjer-Nielsen, Lars; Cebon, Jonathan S ; McCluskey, James; Chen, Weisan; Rossjohn, Jamie |
| 4 | Mar-2017 | A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant | Davis, Ian D; Quirk, Juliet; Morris, Leone; Seddon, Lauren; Tai, Tsin Yee; Whitty, Genevieve; Cavicchiolo, Tina; Ebert, Lisa; Jackson, Heather; Browning, Judy; MacGregor, Duncan; Wittke, Frederick; Winkels, Gregor; Alex, Regina; Miloradovic, Lena; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S |
| 5 | 7-Feb-2015 | Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma. | Klein, Oliver ; Davis, Ian D; McArthur, Grant A; Chen, Li; Haydon, Andrew; Parente, Phillip; Dimopoulos, Nektaria; Jackson, Heather M; Xiao, Kun; Maraskovsky, Eugene; Hopkins, Wendie; Stan, Rodica; Chen, Weisan; Cebon, Jonathan S |
| 6 | 15-Jan-2014 | FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. | Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M |
| 7 | 27-Feb-2013 | Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein. | Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan S ; Itoh, Kyogo; Chen, Weisan |
| 8 | 26-Oct-2012 | A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma. | Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 9 | 6-Sep-2012 | A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen. | Zhao, Rona Y; Mifsud, Nicole A; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J; Lowen, Tamara; Robson, Neil C; Russell, Sarah E; Scotet, Emmanuel; Davis, Ian D; Maraskovsky, Eugene; Cebon, Jonathan S ; Luescher, Immanuel F; Chen, Weisan |
| 10 | 13-Jan-2012 | A novel method for detecting antigen-specific human regulatory T cells. | Ebert, Lisa M; MacRaild, Sarah E; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 11 | 23-Jun-2011 | Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™. | Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S |
| 12 | 1-Jun-2011 | Melanoma vaccines: developments over the past 10 years. | Klein, Oliver ; Schmidt, Christopher; Knights, Ashley J; Davis, Ian D; Chen, Weisan; Cebon, Jonathan S |
| 13 | 18-Oct-2010 | Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion. | Wei, Joe; Waithman, Jason; Lata, Roleen; Mifsud, Nicole A; Cebon, Jonathan S ; Kay, Thomas; Smyth, Mark J; Sadler, Anthony J; Chen, Weisan |
| 14 | 1-Jun-2010 | Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1. | Cebon, Jonathan S ; Knights, Ashley J; Ebert, Lisa; Jackson, Heather M; Chen, Weisan |
| 15 | 29-Apr-2010 | Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery. | Robson, Neil C; McAlpine, Tristan; Knights, Ashley J; Schnurr, Max; Shin, Amanda; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S |
| 16 | 10-Mar-2009 | Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. | Nicholaou, Theo; Ebert, Lisa M; Davis, Ian D; McArthur, Grant A; Jackson, Heather M; Dimopoulos, Nektaria; Tan, Bee; Maraskovsky, Eugene; Miloradovic, Lena; Hopkins, Wendie; Pan, Linda; Venhaus, Ralph; Hoffman, Eric W; Chen, Weisan; Cebon, Jonathan S |
| 17 | 27-Jan-2009 | A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. | Ebert, Lisa M; Liu, Yu Chih; Clements, Craig S; Robson, Neil C; Jackson, Heather M; Markby, Jessica L; Dimopoulos, Nektaria; Tan, Bee Shin; Luescher, Immanuel F; Davis, Ian D; Rossjohn, Jamie; Cebon, Jonathan S ; Purcell, Anthony W; Chen, Weisan |
| 18 | 15-Apr-2008 | The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. | Ebert, Lisa M; Tan, Bee Shin; Browning, Judy; Svobodova, Suzanne; Russell, Sarah E; Kirkpatrick, Naomi; Gedye, Craig; Moss, Denis; Ng, Sweet Ping ; MacGregor, Duncan; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 19 | 10-Sep-2006 | Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. | Davis, Ian D; Chen, Qiyuan; Morris, Leone; Quirk, Juliet; Stanley, Maureen; Tavarnesi, Maria L; Parente, Phillip; Cavicchiolo, Tina; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin Yee; MacGregor, Duncan; Browning, Judy; Svobodova, Suzanne; Caron, Dania; Maraskovsky, Eugene; Old, Lloyd J; Chen, Weisan; Cebon, Jonathan S |
| 20 | 1-Jun-2006 | Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. | Nicholaou, Theo; Ebert, Lisa; Davis, Ian D; Robson, Neil; Klein, Oliver ; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S |
Loading...
2
0
20
0
false
0000-0002-3898-950x